Comparing two biopsy methods for diagnosing lymphoma in the chest
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests if a newer, freezing biopsy method (cryobiopsy) is better than standard needle biopsy for diagnosing lymphoma in lymph nodes between the lungs. It could help avoid more invasive surgeries.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have enlarged lymph nodes in the middle of the chest that doctors cannot explain yet.
- Your doctor suspects lymphoma based on a past history, other lymphoma sites, or specific chest imaging findings.
- You do not have a more likely cause for the enlarged nodes, such as lung cancer or other non-lymphoma cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to take a tissue sample from swollen lymph nodes in the chest using a special microscope and a freezing biopsy tool. The goal is to see if this method is safe and effective for diagnosing the cause of the enlarged nodes.
This study tests a new method that uses a special microscope during a routine lymph node biopsy procedure to see if it can help doctors get more accurate samples. It may improve diagnosis for patients with enlarged lymph nodes in the chest without known lung cancer.
This trial is studying a procedure called cryobiopsy, which uses extreme cold to take tissue samples from the lungs. It aims to see how safe and effective it is for diagnosing conditions like interstitial lung disease or lung cancer, especially when other tests haven't worked.
This trial uses a special ultrasound-guided procedure to take tissue samples from swollen lymph nodes in the chest. It aims to improve diagnosis for people who already need a bronchoscopy.
This trial compares two ways to take tissue samples from swollen lymph nodes in the chest. The goal is to see if a newer technique called EBUS-TTFB gets better samples than the standard method (EBUS-TBNA) when the first samples aren't enough.
This study compares two ways to get a larger tissue sample from lymph nodes in the chest after a first small test confirmed cancer. The goal is to see which method provides better material for detailed genetic testing (next generation sequencing) that can guide treatment choices.
Hear when a new Mediastinal and Hilar Lymphadenopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.